Trial Profile
Phase IIb trial of inhaled form of mercaptamine [Lynovex] in patients with cystic fibrosis
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 03 Mar 2021
Price :
$35
*
At a glance
- Drugs Mercaptamine (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- 26 Feb 2021 According to a Novabiotics media release, this study will begin in H2 2021.
- 15 Jun 2015 New trial record